In our previous publication, we linked high circulating levels of adiponectin with a 64.2% decreased risk of endometrial cancer (Odds Ratio = 0.358, 95% CI: 0.216–0.594, p = 0.0002) [28]. This evidence concerns the gene ADIPOQ and endometrial cancer.